Malignant Esophageal Neoplasm — Trials

Malignant Esophageal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,926 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 518
Recruiting: 303
Ph III recruiting: 41
Growth YoY: +2.4%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 28.5%
Trials / 1,000 deaths: 32.3 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (169)

clinicaltrialsPublishedShowing 201–250 of 660 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07663786	Evaluation of Esophagogastric Cancer Treatment With Nivolumab in Daily Clinical Practice	active not recruiting	—	726	Bristol-Myers SquibbINDUSTRY	1	Jun 23, 2026	clinicaltrials
NCT06545331	Study of XB010 in Subjects With Solid Tumors	recruiting	Phase 1	396	ExelixisINDUSTRY	2	Jun 22, 2026	clinicaltrials
NCT06971848